Nervgen Pharma Corp Stock Price on December 2, 2024
| NGEN Stock | CAD 2.52 0.12 4.55% |
Below is the normalized historical share price chart for NervGen Pharma Corp extending back to March 15, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of NervGen Pharma stands at 2.52, as last reported on the 12th of December 2024, with the highest price reaching 2.64 and the lowest price hitting 2.50 during the day.
If you're considering investing in NervGen Stock, it is important to understand the factors that can impact its price. At this stage we consider NervGen Stock to be very risky. NervGen Pharma Corp has Sharpe Ratio of 0.0237, which conveys that the firm had a 0.0237% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for NervGen Pharma, which you can use to evaluate the volatility of the firm. Please verify NervGen Pharma's Risk Adjusted Performance of 0.0143, downside deviation of 4.81, and Mean Deviation of 3.18 to check out if the risk estimate we provide is consistent with the expected return of 0.11%.
At this time, NervGen Pharma's Liabilities And Stockholders Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to climb to about 14.3 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 41.5 M in 2024. . Price Earnings Ratio is likely to drop to -7.51 in 2024. Price Book Value Ratio is likely to drop to -83.66 in 2024. NervGen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 2.5299 | 50 Day MA 2.5086 | Beta 1.351 |
NervGen |
Sharpe Ratio = 0.0237
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | NGEN | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.72 actual daily | 42 58% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average NervGen Pharma is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NervGen Pharma by adding it to a well-diversified portfolio.
Price Book 19.3042 | Book Value (0.03) | Enterprise Value 156.3 M | Enterprise Value Ebitda (4.54) | Shares Float 58.2 M |
NervGen Pharma Valuation on December 2, 2024
It is possible to determine the worth of NervGen Pharma on a given historical date. On December 2, 2024 NervGen was worth 2.89 at the beginning of the trading date compared to the closed value of 2.88. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NervGen Pharma stock. Still, in general, we apply an absolute valuation method to find NervGen Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NervGen Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NervGen Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 2.77 | 2.89 | 2.74 | 2.87 | 41,489 | |
12/02/2024 | 2.89 | 2.95 | 2.86 | 2.88 | 31,813 |
| 2.87 | 3.00 | 2.87 | 2.88 | 23,600 |
| Backtest NervGen Pharma | | | NervGen Pharma History | | | NervGen Pharma Valuation | Previous | Next |
NervGen Pharma Trading Date Momentum on December 2, 2024
| On December 03 2024 NervGen Pharma Corp was traded for 2.88 at the closing time. The maximum traded price for the trading interval was 3.00 and the lowest daily price was 2.87 . The daily volume was recorded at 23.6 K. The volume of trading on 3rd of December 2024 did not cause price change. The trading delta at closing time to the closing price today is 8.33% . |
NervGen Pharma Corp Fundamentals Correlations and Trends
By evaluating NervGen Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NervGen Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NervGen financial account trend analysis is a perfect complement when working with valuation or volatility modules.About NervGen Pharma Stock history
NervGen Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NervGen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NervGen Pharma Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NervGen Pharma stock prices may prove useful in developing a viable investing in NervGen Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 59.6 M | 41.5 M | |
| Net Loss | -18.7 M | -17.7 M |
NervGen Pharma Stock Technical Analysis
NervGen Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
NervGen Pharma Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
NervGen Pharma Corp cannot be verified against its exchange. Please verify the symbol is currently traded on TSX Venture Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
NervGen Pharma December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how NervGen Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NervGen Pharma shares will generate the highest return on investment. By undertsting and applying NervGen Pharma stock market strength indicators, traders can identify NervGen Pharma Corp entry and exit signals to maximize returns
NervGen Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NervGen Pharma's price direction in advance. Along with the technical and fundamental analysis of NervGen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NervGen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0143 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.71) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0704 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for NervGen Stock Analysis
When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.